Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€16.50

€16.50

0.610%
0.1
0.610%
-
 
14.05.24 / Stuttgart Stock Exchange WKN: A2N9MM / Name: Marinomed Biotech / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Marinomed Biotech

sharewise wants to provide you with the best news and tools for Marinomed Biotech, so we directly link to the best financial data sources.

News

EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
EQS-News: Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
EQS-News: Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
EQS-News: Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
EQS-News: Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico
EQS-News: Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico
EQS-News: Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico
EQS-News: Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months
EQS-News: Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months
EQS-News: Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months
EQS-News: Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
EQS-News: Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
EQS-News: Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
EQS-News: Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations
EQS-News: Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations
EQS-News: Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations